2025
|
P/S
|
Distributorship of pain relief medications; distributorship of pharmaceutical medicines and prepa... |
2024
|
P/S
|
PHARMACEUTICAL PREPARATIONS WHICH ACT ON THE CENTRAL NERVOUS SYSTEM, INCLUDING MODIFIED RELEASE A... |
|
P/S
|
Pharmaceutical preparations which act on the central nervous system, including modified release a... |
|
P/S
|
Pharmaceutical or medical preparations in liquid dosage form, including, drug delivery systems co... |
|
Invention
|
Methods for improving driving behavior.
Use of an oral amphetamine extended release solid dose f... |
|
Invention
|
Low sodium oxybate once nightly composition. Compositions providing a once-a-night dose of oxybat... |
|
Invention
|
Liquid clonidine extended release composition.
An oral clonidine dosage unit providing a twenty-... |
2023
|
Invention
|
Ghb pharmaceutical compositions comprising a floating interpenetrating polymer network forming sy... |
|
Invention
|
Methylphenidate extended release chewable tablet.
An oral methylphenidate extended release table... |
|
Invention
|
Extended release amphetamine tablets. An oral amphetamine extended release solid dose is describe... |
|
Invention
|
Extended release amphetamine compositions.
An oral amphetamine extended release liquid suspensio... |
2022
|
Invention
|
Novel clonidine formulation.
An oral clonidine dosage unit providing a twenty-four hour extended... |
|
Invention
|
Oxybate polyethylene glycol prodrugs.
Oxybate-PEG ester prodrugs are provided herein in which th... |
|
Invention
|
Oxybate polyethylene glycol prodrugs. Oxybate-PEG ester prodrugs are provided herein in which the... |
|
Invention
|
Oxybate - cyclodextrin products and conjugates. Oxybate cyclodextrin mono-esters, di-esters, and ... |
|
Invention
|
Pharmaceutical composition comprising ghb gastro-retentive raft forming systems having trigger pu... |
|
Invention
|
Modified release drug powder composition comprising gastro-retentive raft forming systems having ... |
|
Invention
|
Modified release formulations containing drug-ion exchange resin complexes.
A particulate, modif... |
|
Invention
|
Benzonatate modified release solid tablets and capsules. A modified release benzonatate solid tab... |
2021
|
Invention
|
Benzonatate modified release solid tablets and capsules. A 12-hour anti-tussive modified release ... |
|
Invention
|
Liquid clonidine extended release composition. An oral clonidine dosage unit providing a twenty-f... |
|
Invention
|
Methylphenidate extended release chewable tablet. An oral methylphenidate extended release tablet... |
|
P/S
|
Pharmaceutical preparations. |
|
Invention
|
Modified release formulations containing drug-ion exchange resin complexes.
An aqueous liquid su... |
2020
|
P/S
|
Pharmaceutical preparations, namely, beta-Hydroxy beta-methylglutaryl-CoA (HMG-CoA) reductase inh... |
2019
|
Invention
|
Modified release formulations containing drug-ion exchange resin complexes. An aqueous liquid sus... |
|
P/S
|
Pharmaceutical preparations which act on the central nervous system, namely modified release and ... |
|
P/S
|
Pharmaceutical preparations, namely, pharmaceutical preparations containing the drug clonidine, i... |
|
Invention
|
Extended release amphetamine compositions. An oral amphetamine extended release liquid suspension... |
2018
|
Invention
|
Pharmaceutical compositions comprising a floating interpenetrating polymer network forming system... |
2017
|
Invention
|
Benzonatate modified release solid tablets and capsules.
A modified release benzonatate solid ta... |
|
Invention
|
Modified release formulations containing drug-ion exchange resin complexes. A particulate, modifi... |
2016
|
Invention
|
Orally effective methylphenidate extended release powder and aqueous suspension product.
An oral... |
2015
|
P/S
|
Pharmaceutical preparations for treating coughs, colds, allergies and respiratory diseases, and s... |
|
P/S
|
Oral modified release, extended release, and/or sustained release pharmaceutical preparations for... |
2013
|
P/S
|
Pharmaceutical preparations for treating coughs, colds, allergies, and respiratory diseases, and ... |
2008
|
P/S
|
Pharmaceutical or medical preparations in liquid dosage form, namely, drug delivery systems compr... |
2004
|
P/S
|
Scientific research program for the development of preparations or products in liquid form that d... |
2000
|
P/S
|
Scientific research and development for pharmaceuticals, neutraceuticals, drug delivery products ... |